Global Bio & Investment Monthly
Media Production and Publishing • 
Xinyi District, Taipei City, Taiwan, Province of China • 11-20 Employees
Company overview
| Headquarters | 29, Sec. 6, Xinyi Rd., Xinyi Dist, Rm#2-1, Taipei City, 110, TW |
| Phone number | +886227261065 |
| Website | |
| Keywords | Healthcare, Biotech, News, Medtech, Pharmtech |
| Founded | 2013 |
| Employees | 11-20 |
| Socials |
Key Contacts at Global Bio & Investment Monthly
Peng Alice
Senior Editorial Director
林璦 李
Editorial Director
小明 Lin
Chief Executive Officer
Global Bio & Investment Monthly Email Formats
Global Bio & Investment Monthly uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@gbimonthly.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@gbimonthly.com | 100% |
About Global Bio & Investment Monthly
Global Bio & Investment Monthly, also known as GBI Monthly in Taiwan, is a professional media platform focusing on biotechnology, pharmaceutical and healthcare industry. GBI Monthly is the only existing and longest-running paper magazine focusing on the Chinese biomedical industry. As the most influential and informative professional media in the field, it covers a wide range of biomedical topics published by a team of experts with independent editorial and production capabilities. GBI also provides a precise online directory of biomedical vendors. With a deep involvement in the industry and excellent interaction, GBI has become the first choice for media cooperation among governments, research institutions, industry organizations, and medical systems. It has an extremely rich database of industry news and conducts various biomedical industry surveys, covering advanced biotechnology, pharmaceuticals, medical devices, life sciences, capital investment, industry policies, and more. GBI is an important portal and information platform for the Taiwan biomedical industry, connecting local and international networks. Currently, GBI is expanding its reach on various high-impact biomedical topics, developing multilingual services, connecting with international biomedical media, and collaborating with asset valuation agencies. It continues to conduct deep industry research and analysis and provide detailed reports to support stakeholders in making informed decisions. Media features 1. Dimensions ：21.5 * 28 cm 2. Date of issue：Daily(Online), Monthly(Print) 3. Target Audience：Professionals in biotechnology, healthcare, pharmaceutical, investment corporations and institutions
Global Bio & Investment Monthly revenue & valuation
| Annual revenue | $941,105 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Media Production and Publishing industry and current estimated revenues | $3,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Global Bio & Investment Monthly has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Global Bio & Investment Monthly has never raised funding before.
Global Bio & Investment Monthly Tech Stack
Discover the technologies and tools that power Global Bio & Investment Monthly's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Advertising
Security
Programming languages
Analytics
Video players
UI frameworks
Advertising
Germany
Gibraltar
Hong Kong
United States
NetherlandsFrequently asked questions
4.8
40,000 users
